𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis B mass immunization of adolescents: A pilot study in a community

✍ Scribed by S. Plaitano; L. Sagliocca; A. Mele; C. Bove; D. Protano; B. Adamo; F. Palumbo; M. Cauletti; E. Franco; P. Pasquini


Book ID
104640966
Publisher
Springer
Year
1993
Tongue
English
Weight
349 KB
Volume
9
Category
Article
ISSN
0393-2990

No coin nor oath required. For personal study only.

✦ Synopsis


The National Type Specific Hepatitis Surveillance System (SEIEVA) and seroepidemiological studies have shown that in addition to newborns from mothers who are carriers for hepatitis B surface antigen (HBsAg), adolescents are at high risk of acquiring type B hepatitis virus because of increasing importance of the heterosexual transmission of this virus. In order to evaluate logistic problems and acceptance rate of adolescents to mass vaccination against hepatitis B, a pilot study was carried out among all 7th grade children registered in the 9 schools of an hepatitis B endemic area located in the suburbs of Naples. After meetings held by the local health department with school teachers and parents, 1219 out of 1250 (97.5%) invited children received the first dose of hepatitis B vaccine; 1215 and 1209 received, respectively, the second and third doses. Anti-hepatitis B surface antigen (anti-HBs) values were studied in 406 subjects one month after the third dose, and 21 out of 406 (5.2%) had anti-HBs values less than 10 IU/L. We consider 95Β°/0 of subjects with anti-HBs values greater than 9 IU/L a good achievement for a field vaccination program. The high acceptance rate of vaccination found in our study outlines the importance of active offer of vaccination combined with school involvement.


πŸ“œ SIMILAR VOLUMES


Treatment of chronic non-A, non-B hepati
✍ S. Chris Pappas; Dr. Jay H. Hoofnagle; Neal Young; Stephen E. Straus; E. Anthony πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 576 KB

Five patients with chronic non-A, non-B hepatitis were entered into a pilot therapeutic study of the antiviral agent acyclovir [9-(2-hydroxyethoxymethyl) guanine]. Each patient received acyclovir by slow intravenous infusion in a dosage of 5 mg/kg every 8 hr for 10 days. During therapy, serum aminot

Seroepidemiology of hepatitis A and hepa
✍ K. T. Goh; K. H. Kong; B. H. Heng; C. J. Oon πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 439 KB

## Abstract The overall prevalence of hepatitis A virus (HAV) infection among the Gurkhas and their families stationed in Singapore was 83.2%, with antibody to HAV detected in 67 (38.1%) of 176 children under 5 years of age, 121 (76.6%) of 158 children between 5 and 14 years, and 600 (97.9%) of 613